A Doctor's Visit in 1965 Cost Less Than Your Lunch Today. Here's the Catch.

In 1965, you could walk into a general practitioner's office in most American cities, get examined, and walk out having paid somewhere between three and five dollars. No co-pay confusion, no prior authorization, no explanation of benefits arriving in the mail three weeks later. You had a problem, you saw a doctor, you paid a modest fee, and you went home.

Adjusted for inflation, that visit would cost roughly $30 today. The average actual cost of a primary care visit in 2024? Somewhere between $250 and $400 before insurance discounts are applied.

That gap is enormous. And it tells a story that's more complicated — and more interesting — than it first appears.

What Medicine Looked Like Before Medicare

The year 1965 is a useful anchor because it's the year Medicare and Medicaid were signed into law, fundamentally reshaping how Americans paid for healthcare. Before that, the system was simpler in structure but brutal in its limitations.

Most Americans paid their doctors directly. Health insurance existed but wasn't nearly as widespread as it would become — roughly 70% of Americans had some form of hospital coverage by the mid-60s, but physician visit coverage was far patchier. For routine care, you paid cash. For serious illness or surgery, you hoped your savings held out.

The costs were genuinely low by today's standards. A hospital stay in 1965 averaged around $40 per day — about $380 adjusted for inflation. Compare that to today's average of roughly $2,800 per day and the numbers become almost surreal.

But here's the part that often gets left out of the "healthcare used to be affordable" conversation: what you were actually buying for that money was radically different.

The Limits of Cheap Care

In 1965, if you had a heart attack, your doctor's primary tools were rest, morphine for the pain, and hope. The coronary care unit — a specialized ward designed specifically to monitor and treat cardiac events — had only just been invented. Bypass surgery was experimental. Statins didn't exist. The clot-busting drugs that can now stop a heart attack mid-event were decades away.

The survival rate for a heart attack in the mid-1960s was somewhere around 30% if you made it to the hospital. Today it's closer to 90-95% with prompt treatment.

Cancer treatment in 1965 largely meant surgery and radiation. Chemotherapy was in its infancy. Many cancers that are now manageable chronic conditions — certain leukemias, some breast cancers, thyroid cancer — were effectively death sentences. HIV/AIDS, which would emerge two decades later, would have been completely untreatable. Hepatitis C, now curable in eight weeks with a pill, would have progressed silently to liver failure.

The affordable doctor's visit of 1965 was, in many cases, a visit to someone who could comfort you but not necessarily cure you. The low price reflected, at least in part, a lower ceiling on what medicine could actually accomplish.

So Why Does It Cost So Much More Now?

The reasons are numerous and genuinely contested among economists and healthcare policy experts, but a few factors stand out.

First, the technology itself is expensive to develop, purchase, and maintain. An MRI machine costs millions of dollars. The drugs that cure hepatitis C cost tens of billions to develop. That investment gets priced into care.

Second, the administrative infrastructure of modern American healthcare — insurance billing, compliance, coding, prior authorizations — has grown into a massive cost center of its own. Studies suggest that administrative costs account for roughly 25-35% of total US healthcare spending, a proportion significantly higher than in most other developed countries.

Third, the consolidation of hospital systems and the decline of independent physician practices have reduced competitive pressure on pricing in many markets.

And fourth — though this is more contentious — the structure of third-party payment, where insurers rather than patients pay most bills, has historically reduced price sensitivity in ways that can allow costs to rise without the natural check that direct consumer spending provides.

The Tension Nobody Has Solved

What makes American healthcare in 2025 such a genuinely difficult topic is that both things are true simultaneously: care is more powerful than it has ever been, and it is harder to access than it should be.

About 25 million Americans remain uninsured. Medical debt is the leading cause of personal bankruptcy in the United States — a phenomenon that essentially doesn't exist in most other wealthy nations. People skip prescriptions, delay diagnoses, and avoid the doctor not because medicine can't help them but because the financial risk of engaging with the system feels too high.

In 1965, you might have walked in, paid your five dollars, and been told there wasn't much to be done. In 2025, there is often a great deal that can be done — but the bill for doing it can follow you for years.

The now gap in American healthcare isn't just the distance between a $4 office visit and a $350 one. It's the space between a system that was financially accessible but medically limited, and one that is medically extraordinary but financially out of reach for too many people.

Progress and access haven't kept pace with each other. And that gap, more than any dollar figure, is the story worth sitting with.